NO980317L - Anvendelse av Calendula-glykosider for behandling av psoriasis - Google Patents

Anvendelse av Calendula-glykosider for behandling av psoriasis

Info

Publication number
NO980317L
NO980317L NO980317A NO980317A NO980317L NO 980317 L NO980317 L NO 980317L NO 980317 A NO980317 A NO 980317A NO 980317 A NO980317 A NO 980317A NO 980317 L NO980317 L NO 980317L
Authority
NO
Norway
Prior art keywords
psoriasis
calendula
glycosides
treatment
compounds
Prior art date
Application number
NO980317A
Other languages
English (en)
Norwegian (no)
Other versions
NO980317D0 (no
Inventor
Solomon Habtemariam
William Howard Stimson
Alexander Irvine Gray
Chaman Lal Anand
Peter George Waterman
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Publication of NO980317D0 publication Critical patent/NO980317D0/no
Publication of NO980317L publication Critical patent/NO980317L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
NO980317A 1995-07-25 1998-01-23 Anvendelse av Calendula-glykosider for behandling av psoriasis NO980317L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515214.6A GB9515214D0 (en) 1995-07-25 1995-07-25 Plant extracts
PCT/GB1996/001792 WO1997004788A2 (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis

Publications (2)

Publication Number Publication Date
NO980317D0 NO980317D0 (no) 1998-01-23
NO980317L true NO980317L (no) 1998-03-24

Family

ID=10778203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980317A NO980317L (no) 1995-07-25 1998-01-23 Anvendelse av Calendula-glykosider for behandling av psoriasis

Country Status (22)

Country Link
US (1) US6225342B1 (de)
EP (1) EP0848612B1 (de)
JP (1) JP4384261B2 (de)
KR (1) KR19990035847A (de)
CN (1) CN1191488A (de)
AT (1) ATE236643T1 (de)
AU (1) AU6621096A (de)
BG (1) BG102250A (de)
BR (1) BR9609910A (de)
CA (1) CA2227751A1 (de)
CZ (1) CZ19498A3 (de)
DE (1) DE69627354T2 (de)
EE (1) EE9800032A (de)
ES (1) ES2197242T3 (de)
GB (1) GB9515214D0 (de)
HU (1) HUP9802861A3 (de)
IS (1) IS4651A (de)
NO (1) NO980317L (de)
PL (1) PL324655A1 (de)
SK (1) SK9498A3 (de)
WO (1) WO1997004788A2 (de)
ZA (1) ZA966298B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
GB9701415D0 (en) 1997-01-24 1997-03-12 Univ Strathclyde Stereoisomers
GB9809889D0 (en) 1998-05-11 1998-07-08 Univ Strathclyde Prevention of restenosis
AU784718B2 (en) * 1999-07-09 2006-06-01 Bsp Pharma A/S Composition containing extracts of Butyrospermum parkii and the use as medicament or dietary supplement
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US20040033267A1 (en) * 2002-03-20 2004-02-19 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US7887860B2 (en) * 2001-12-28 2011-02-15 Inter American University Of Puerto Rico Anti-bacterial plant compositions
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20050152996A1 (en) * 2003-12-01 2005-07-14 BUTLER Donald Extracts of Mimulus aurantiacus for treating psoriasis and repelling insects
BG65694B1 (bg) * 2003-12-31 2009-07-31 Владимир НАЙДЕНОВ Средство за лечение на дерматози
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
CA3107707A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN109516983A (zh) * 2018-11-20 2019-03-26 广东药科大学 一种中药草本祛痘化合物及其组合物
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN114159453A (zh) 2021-12-24 2022-03-11 广西馨海药业科技有限公司 白头翁皂苷b4在制备治疗或预防银屑病的药物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2056A1 (fr) 1987-12-23 1990-09-04 Psoricur Ltd Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
DE3836519C2 (de) * 1988-10-26 1994-03-10 Cutan Kosmetik Vertriebs Gmbh Verwendung einer pharmazeutischen Zubereitung auf der Basis von Calendula officinalis zur Behandlung von Psoriasis
HU203668B (en) 1990-04-03 1991-09-30 Tamas Angeli Cosmetic containing medicinal plants and process for producing composition against psoriasis

Also Published As

Publication number Publication date
KR19990035847A (ko) 1999-05-25
WO1997004788A3 (en) 1997-03-27
CZ19498A3 (cs) 1998-09-16
ES2197242T3 (es) 2004-01-01
EP0848612A2 (de) 1998-06-24
AU6621096A (en) 1997-02-26
JP4384261B2 (ja) 2009-12-16
PL324655A1 (en) 1998-06-08
HUP9802861A2 (hu) 1999-04-28
GB9515214D0 (en) 1995-09-20
MX9800697A (es) 1998-09-30
BG102250A (en) 1999-02-26
CA2227751A1 (en) 1997-02-13
ATE236643T1 (de) 2003-04-15
EE9800032A (et) 1998-08-17
US6225342B1 (en) 2001-05-01
EP0848612B1 (de) 2003-04-09
HUP9802861A3 (en) 1999-08-30
WO1997004788A2 (en) 1997-02-13
IS4651A (is) 1998-01-16
SK9498A3 (en) 1998-09-09
DE69627354T2 (de) 2004-03-04
DE69627354D1 (de) 2003-05-15
ZA966298B (en) 1997-02-11
CN1191488A (zh) 1998-08-26
BR9609910A (pt) 1999-06-15
NO980317D0 (no) 1998-01-23
JPH11510153A (ja) 1999-09-07

Similar Documents

Publication Publication Date Title
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
ATE255589T1 (de) Kristallin form i von clarithromycin
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
BG101118A (en) Therapeutical compounds
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
NO934706L (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
EP0443957A3 (en) New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
IT8609514A0 (it) Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.